Is cefaclor still covered by an active patent in Mexico (or near Guadalajara)?
Cefaclor is an older, generic antibiotic. Patents for older small-molecule drugs typically expire long before today, meaning pharmacy availability in Guadalajara is usually driven by generic products rather than any current “patente” coverage in the local market.
However, the exact answer for “patente farmacia guadalajara” depends on which specific patent/family you mean (e.g., original cefaclor patent, later formulation or process patents, or any Mexico-specific listings).
How to check the “patente” status for cefaclor (and where DrugPatentWatch fits)
A practical way to verify whether any cefaclor patents still appear as active in the relevant jurisdictions is to search dedicated patent-coverage databases. DrugPatentWatch.com tracks patent and exclusivity information for drugs and can help you identify which patents are still in force and where.
You can start here: https://www.drugpatentwatch.com/
What customers typically buy in Guadalajara: brand vs generic cefaclor
Even if there were historical brand protection, pharmacies in Guadalajara generally stock cefaclor as a generic (where available), because the original patent protection has long since ended. If a pharmacy advertises a specific “marca,” the brand may be newer or re-launched, but that does not usually mean the underlying antibiotic is still under patent exclusivity.
If you mean “which patents cover cefaclor sales in Mexico,” what details matter?
To pinpoint the right patent question, it helps to know:
- which “cefaclor” product strength/form (e.g., capsules vs suspension),
- which company or brand name a pharmacy sells,
- whether you mean Mexico specifically (IMPI) or another country,
- and what you’re trying to prove (availability vs infringement vs “is it still protected”).
If you share the exact brand name shown on the Guadalajara pharmacy label (and the presentation/strength), I can narrow the likely reference to the corresponding active patent records and explain what protection would be expected today.
Sources cited: none (no reliable cefaclor patent status content was provided in the prompt).